Emphysema clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
- Gene Therapy for Alpha 1- Antitrypsin Deficiency
- A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- STRIVE Post-Market Registry Study
- PiMZ Longitudinal Cohort (PiMZ Logic)
- COPD Patient-Powered Research Network
- Emphysema Research Registry and Biosample Repository
- Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Emphysema” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.